Hyperkalemic periodic paralysis associated with thyrotoxicosis.
A 32 year old male presented with episodic pure motor weakness for 1 1/2 months. On evaluation he was found to be thyrotoxic. Hyperkalemic challenge test provoked similar weakness with raised serum potassium (6 meq/L). He responded to treatment with neomercazole. Till he became euthyroid, he responded to the addition of acetazolamide to his medication. He is symptom free on antithyroid drug alone over 8 months of follow up.
Ghosh
D
D
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow.
Trivedi
N
N
Kohli
A
A
Mithal
A
A
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D002231:Carbimazole / Q000627:therapeutic use; D004576:Electromyography; D006801:Humans; D006947:Hyperkalemia / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D010243:Paralysis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D013971:Thyrotoxicosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
D002231:Carbimazole; D000086:Acetazolamide